SmartCT Angio Imaging technology

SmartCT Angio

Imaging technology

OPT18

Find similar products

This X-ray acquisition technique generates a complete high-resolution 3D visualization of cerebral, cardiac, abdominal or peripheral vasculature from a single rotational angiography run – all controlled via the touch screen at the table. This can improve visibility of tortuous or complex anatomy that may not be seen on a 2D or DSA image.

Features
Easily adopt 3D imaging in the lab
Easily adopt 3D imaging in the lab

Easily adopt 3D imaging in the lab

3D imaging can enhance diagnostic accuracy [1], improve patient outcomes [2,3] and increase procedural efficiency in the interventional lab. Despite these advantages, the acquisition and processing of these images was sometimes perceived as a workflow hurdle. To take the guesswork out of 3D acquisition, SmartCT provides step-by-step guidance and visual assistance during acquisition to help easily perform 3D imaging.[4]
3D imaging at table side
3D imaging at table side

3D imaging at table side

With the touch screen, you can easily acquire 3D images and interact with SmartCT tools in a natural and effortless way. Once acquired, the SmartCT viewing application automatically opens your 3D image with the correct rendering and viewing tools on the touch screen module. All tools work with touch screen simplicity within the sterile area.
Reveal information not apparent on 2D or DSA images
Reveal information not apparent on 2D or DSA images

Reveal information not apparent on 2D or DSA images

SmartCT offers advanced reconstruction techniques to improve anatomical visualization. Once acquired, you can manipulate advanced visualizations such as 3D MPR on the table side touch screen to evaluate the type and extent of disease and surrounding tissues with great detail. SmartCT 3D images can help reveal information not apparent on 2D or DSA images, which can impact clinical decisions.
SmartCT Vessel Analysis supports treatment planning
SmartCT Vessel Analysis supports treatment planning

SmartCT Vessel Analysis supports treatment planning

Select two points of a vessel to quickly define a vessel path on a 3D volume. The path is automatically detected and rendered in different views to support easy inspection of vessel and device positioning with straightened, curved and cross-section reformats. The vessel dimensions are automatically extracted, and landing zones can be specified and later overlaid on live fluoroscopy. Finally, optimal projection angles for catheterization can be identified and later recalled with a single button press.
Easily perform two-point measurements on screen
Easily perform two-point measurements on screen

Easily perform two-point measurements on screen

uickly measure distances on a 2D or 3D image with two-point measurements on the touch screen. This can help quickly check the trajectory to a target vessel, measure distances for stent deployment, measure the size of anatomy or identify a discrepancy to speed up planning of the optimal treatment angle and aid navigation.
Quickly define any structure of interest
Quickly define any structure of interest

Quickly define any structure of interest

The SmartCT semi-automatic lesion segmentation tool allows you to easily define any structure of interest, measure its volume and remove anatomy to improve visualization.
  • 1. Schott P, Katoh M, Fischer N, Freyhardt P. Radiation Dose in Prostatic Artery Embolization Using Cone-Beam CT and 3D Roadmap Software. J Vasc Interv Radiol. 2019 Sep;30(9):1452-1458. doi: 10.1016/j.jvir.2019.04.040. Epub 2019 Jul 29.
  • 2. Miyayama S, et al. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography. Cardiovasc Intervent Radiol. 2014 Apr;37(2):388-95. doi: 10.1007/s00270-013-0667-2. Epub 2013 Jun 19.
  • 3. Ribo M, Boned S, Rubiera M, et al. Direct transfer to angiosuite to reduce door-to-puncture time in thrombectomy for acute stroke. J Neurointerv Surg. 2018 Mar;10(3):221-224. doi: 10.1136/neurintsurg-2017-013038. Epub 2017 Apr 26.
  • 4. Evaluated with clinical users in a simulated lab environment with a total of 17 teams consisting of a physician and a radio-tech with different levels of experience As described in the SmartCT Instructions for Use (IFU).
  • SmartCT is currently not available for sale in USA, 510(k) pending. This material is not for distribution in the USA.